LONDON (dpa-AFX) - Smith+Nephew (SN.L, SNN) has received 510(k) clearance
for new CATALYSTEM Primary Hip System from the FDA. It is designed to address
the evolving demands of primary hip surgery including the increased adoption of
anterior approach procedures and the expanding role of Ambulatory Surgery
Centers.

The CATALYSTEM Primary Hip System utilizes patent-pending, ACCUBROACH
Technology. The System features a triple-taper stem design with uniform proximal
loading. The company noted that the reduced distal stem geometry and shorter
lengths are ideal for anterior approach but suitable for all approaches.

For More Such Health News, visit rttnews.com.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX